凝血因子检测在重症肝病中的临床应用

Detection of Clotting Factor in Severe Liver Disease in Clinical Application

目的探讨凝血因子在重症肝病临床诊断中的意义。方法选利用BE Compact全自动血凝仪比色法,对选取的60例患者凝血因子的活性水平进行检测,并选取50例健康人,对其饮血因子活性进行检测作为对照组,与其进行对比。结果经检测发现,60例患者凝血因子的活性水平明显低于50例健康人凝血因子的活性水平。因此,对凝血因子活性水平测定,可以更及时、更准确地为诊断重症肝病提供有效参考依据,提高预后。结论凝血因子活性测定有利于重症肝病的诊断,其可作为肝脏合成的可靠指标。对其进行测定也可全面了解重症肝病患者凝血因子缺乏的程度,以及判断肝功能损害程度,并可采取有效措施进行预防,其对临床诊治重症肝病和指导用药具有重要意义,能有效提高患者预后。

Objective Explore clotting factors in the diagnosis of severe liver disease clinical significance. Methods Choose use BE Compact fully automatic blood coagulation instrument colorimetric method, selection of 60 cases of patients with blood clotting factor activity level testing, and 50 cases of healthy people, to test the its drinking blood factor activity as the control group, comparing with. Results After testing found that the activity of clotting factor levels of 60 patients significantly lower than the activity of 50 cases of healthy human clotting factor levels. Level determination of activity of clotting factors, therefore, can be more timely, more accurate to provide effective reference for diagnosis of severe liver diseases, improve the prognosis. Conclusion Clotting factor activity determination is helpful for the diagnosis of severe liver disease, which can be used as a reliable indicator of liver. To measure can also be a comprehensive understanding of the extent of severe liver disease patients lack of clotting factors, judging and liver function damage degree, and can take effective measures to prevent, its guidance to the clinical treatment of severe liver disease and drug use is of great significance, can effectively improve the prognosis of patients.